High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients With Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696
Kirkwood, John M., Ibrahim, Joseph, Lawson, David H., Atkins, Michael B., Agarwala, Sanjiv S., Collins, Keirsten, Mascari, Ruth, Morrissey, Donna M., Chapman, Paul B.Volume:
19
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2001.19.5.1430
Date:
March, 2001
File:
PDF, 72 KB
english, 2001